002773 Stock Overview
Research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Chengdu Kanghong Pharmaceutical Group Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥19.75 |
52 Week High | CN¥24.50 |
52 Week Low | CN¥13.15 |
Beta | 0.12 |
11 Month Change | -0.15% |
3 Month Change | 4.66% |
1 Year Change | 4.39% |
33 Year Change | 5.90% |
5 Year Change | -49.69% |
Change since IPO | -56.67% |
Recent News & Updates
Recent updates
Shareholder Returns
002773 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 1.9% | -0.6% | -2.8% |
1Y | 4.4% | -8.7% | 2.0% |
Return vs Industry: 002773 exceeded the CN Pharmaceuticals industry which returned -7.9% over the past year.
Return vs Market: 002773 exceeded the CN Market which returned 3.2% over the past year.
Price Volatility
002773 volatility | |
---|---|
002773 Average Weekly Movement | 6.3% |
Pharmaceuticals Industry Average Movement | 7.4% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002773 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002773's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 4,289 | Xiao Ke | www.cnkh.com |
Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. It also develops ophthalmic medical devices. The company offers central nervous, digestive, and endocrine system drugs.
Chengdu Kanghong Pharmaceutical Group Co., Ltd Fundamentals Summary
002773 fundamental statistics | |
---|---|
Market cap | CN¥18.17b |
Earnings (TTM) | CN¥1.19b |
Revenue (TTM) | CN¥4.37b |
15.2x
P/E Ratio4.2x
P/S RatioIs 002773 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002773 income statement (TTM) | |
---|---|
Revenue | CN¥4.37b |
Cost of Revenue | CN¥457.72m |
Gross Profit | CN¥3.91b |
Other Expenses | CN¥2.72b |
Earnings | CN¥1.19b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.30 |
Gross Margin | 89.53% |
Net Profit Margin | 27.30% |
Debt/Equity Ratio | 0% |
How did 002773 perform over the long term?
See historical performance and comparison